Conjugates of oligonucleotides and analogues with cell penetrating peptides as gene silencing agents

Current Pharmaceutical Design

Volumn 11, Issue 28, 2005, Pages 3639-3654

  Zatsepin, T S ^a   Turner, J J ^b   Oretskaya, T S ^a   Gait, M J ^b  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Antisense; Cell penetrating peptide; Conjugate; Gene silencing; Oligonucleotide

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BETA GALACTOSIDASE; CARRIER PROTEIN; CELL PENETRATING PEPTIDE; OLIGONUCLEOTIDE; PEPTIDE NUCLEIC ACID; PHOSPHOROTHIOIC ACID DERIVATIVE; RIBONUCLEASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

CELL LINE; CHEMICAL STRUCTURE; CONJUGATION; DISULFIDE BOND; DRUG DESIGN; DRUG RESEARCH; GENE SILENCING; GENE TARGETING; IN VIVO STUDY; MICHAELIS CONSTANT; NONVIRAL GENE DELIVERY SYSTEM; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW; SOLID PHASE SYNTHESIS; STEREOSPECIFICITY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; SYNTHESIS;

ANIMALS; GENE SILENCING; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; PEPTIDES; RNA, SMALL INTERFERING;

EID: 18844457879     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161205774580769     Document Type: Review

References (122)

1. Thierry AR, Vivès E, Richard J-P, Prevot P, Martinand-Mari C, Robbins I, et al. Cellular uptake and intracellular fate of antisense oligonucleotides. Curr Opin Mol Ther 2003; 5: 133-8.
2. Opalinska JB, Gewirtz AM. Nucleic-acid therapeutics: basic principles and recent applications. Nat Reviews 2002; 1: 503-14.
3. Kurreck J. Antisense technologies. Improvement through novel chemical modifications. Eur J Biochem, 2003; 270: 1628-44.
4. Scherer LJ, Rossi JJ. Approaches for the sequence-specific knockdown of mRNA. Nat Biotech 2003; 21: 1457-65.
5. Faria M, Wood CD, Perrouault L, Nelson JS, Winter A, White MRH, et al. Targeted inhibition of transcription elongation in cells mediated by triplex-forming oligonucleotides. Proc Natl Acad Sci USA 2000; 97: 3862-7.
6. Bennett CF, Chiang M-Y, Chan H, Shoemaker JE, Mirabelli CK. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mot Pharmacol 1992; 41: 1023-33.
7. Shi F, Hoekstra D. Effective delivery of oligonucleotides in order to make sense of antisense. J Control Release 2004; 97: 189-209.
8. Lochmann D, Jauk E, Zimmer A. Drug delivery of oligonucleotides by peptides. Eur J Pharm Biopharm 2004; 58: 237-51.
9. Stetsenko DA, Arzumanov AA, Korshun VA, Gait MJ. Peptide conjugates of oligonucleotides as enhanced antisense agents: a review. Mol Biol (Russ) 2000; 34: 852-9.
10. Gait MJ. Peptide-mediated cellular delivery of antisense oligonucleotides and their analogues. Cell Mol Life Sci 2003; 60: 1-10.
11. Tung C-H, Stein S. Preparation and application of peptide-oligonucleotide conjugates. Bioconj Chem 2000; 11: 605-18.
12. Zubin EM, Romanova EA, Oretskaya TS. Modern methods for the synthesis of peptide-oligonucleotide conjugates. Russ Chem Rev 2002; 71: 239-64.
13. Corey DR. Synthesis of oligonucleotide-peptide and oligonucleotide-protein conjugates. In: Niemeyer CM Ed, Methods of Molecular Biology. Bioconjugation protocols: strategies and methods. New Jersey: Humana Press 2004; 197-206.
14. Stetsenko DA, Gait MI. Chemical methods for peptide-oligonucleotide conjugate synthesis. In: Herdewijn P Ed. Methods of Molecular Biology. Oligonucleotides synthesis. Methods and applications. New Jersey: Humana Press 2004; 205-24.
15. Shabarova ZA. Synthetic nucleotide-peptides. In: Davidson JN, Cohn WE Eds. Progress in Nucleic Acids Research and Molecular Biology. New York: Academic Press 1970; 145-82.
16. Robles J, Pedroso E, Grandas A. Solid-phase synthesis of a nucleopeptide from the linking site of adenovirus-2 nucleoprotein, H-Ser(p5′CATCAT)-Gly-Asp-OH. Convergent stepwise synthesis. Nucl Acids Res 1995; 23: 4151-61.
17. Robles J, Maseda M, Beltran M, Concernau M, Pedroso E, Grandas A. Synthesis and enzymatic stability of phosphodiester-linked peptide-oligonucleotide hybrids. Bioconjugate Chem 1997; 8: 785-8.
18. Sinyakov AN, Lokhov SG, Kutyavin IV, Gamper HB, Meyer RB. Exceptional and selective stabilization of A-T rich DNA-DNA duplexes by N-methylpyrrole carboxamide peptides conjugated to oligodeoxynucleotides. J Amer Chem Soc 1995; 117: 4995-6.
19. Mironova NL, Pyshnyi DV, Ivanova EM, Zenkova MA, Gross HJ, Vlassov VV. Covalendy attached oligodcoxyribonucleotides induce RNase activity of a short peptide and modulate it base specificity. Nucl Acids Res 2004; 32: 1928-36.
20. Shabarova ZA, Ivanovskaya MG, Gottikh MB. N-hydroxybenzotriazole esters of oligonucleotides. A new class of reagents for template-directed synthesis of internucleotide bonds and for obtaining oligonucleotide derivatives. In: Townsend LB, Tipson RS Eds, Nuclelic Acids Chemistry. Improved and new synthetic procedures. Methods and techniques. New York: Wiley 1991; 386-90.
21. Kuznetsova S, Ait-Si-Ali S, Nagibevna I, Troalen F, Le Villain JP, Harel-Bellan A, et al. Gene activation by triplex-forming oligonucleotide coupled to the activating domain of protein VP16. Nucl Acids Res 1999; 27: 3995-4000.
22. Lukhtanov EA, Kuyavin IV, Meyer RB. Direct solid phase assembly of dihydropyroloindole peptides with conjugated oligonucleotides. Bioconjugate Chem 1996; 7: 564-7.
23. de la Torre BG, Albericio F, Saison-Behmoaras E, Bachi A, Eritja R. Synthesis and binding properties of oligonucteotides carrying nuclear localisation sequences. Bioconj Chem 1999; 10: 1005-12.
24. Haralambidis J, Duncan L, Angus K, Tregear GW. The synthesis of polyamide oligonucleotide conjugate molecules. Nucl Acids Res 1990; 18: 493-9.
25. Stetsenko DA, Malakhov AD, Gait MJ. Total stepwise solid-phase synthesis of oligonucleotide (3′→N)-peptide conjugates. Organic Lett 2002; 4: 3259-62.
26. Basu S, Wickstrom E. Solid-phase synthesis of a D-peptide-phosphorothioate oligodeoxymicleotide conjugate from two arms of a polyethylene glycol-polystyrene support. Tetrahedron Lett 1995; 36: 4943-6.
27. Nielsen J, Brenner S, Janda KD. Synthetic methods for the implementation of encoded combinatorial chemistry. J Am Chem Soc 1993; 115: 9812-3.
28. Antopolsky M, Azhayeva E, Tengvall U, Azhayev A. Towards a general method for the stepwise solid-phase synthesis of peptide-oligonucleotide conjugates. Tetrahedron Lett 2002; 43: 527-30.
29. De Napoli L, Messere A, Montesarchio D, Piccialli G, Benedetti E, Bucci E, et al. A new solid-phase synthesis of oligonucleotides 3′-conjugated with peptides. Bioorg Med Chem 1999; 7: 395-400.
30. Terenzi S, Biala E, Nguyen-Trung NQ, Strazewski P. Amphiphilic 3′-peptidyl-RNA conjugates. Angewandte Chem Int Ed 2003; 42: 2909-12.
31. Antopolsky M, Azhayev A. Stepwise solid-phase synthesis of peptide-oligonucleotide conjugates on new solid supports. Helv Chim Acta 1999; 82: 2130-7.
32. Juby CD, Richardson CD, Brousseau R. Facile preparation of 3′ oligonuelcotide-peptide conjugates. Tetrahedron Lett 1991; 32: 879-82.
33. Cutrona G, Carpaneto EM, Ulivi M Roncella S, Landt O, Ferrarini M, et al. Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. Nat Biotech 2000; 18: 300-3.
34. Rapozzi V, Burm BE, Cogioi S, van der Marel GA, van Boom JH, Quadrifoglio F, et al. Anti-proliferative effect in chronic myeloid leukaemia cells by antisense peptide nucleic acids. Nucl Acids Res 2002; 30: 3712-21.
35. Sazani P, Gemignani F, Kang S-H, Maier MA, Manoharan M, Persmark M, et al. Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat Biotech 2002; 20: 1228-33.
36. Galazzi F, Wang Y, Jia F, Shenoy N, Landon LA, Hanninck M, et al. Synthesis of radiometal-labeled and fluorescent cell-permeating peptide-PNA conjugates for targeting the bcl-2 proto-oncogene. Biocorjugate Chem 2003; 14: 1083-95.
37. Richard J-P, Melikov K, Vivès E, Ramos C, Verbeure B, Gait MJ, et al. Cell-penetrating peptides. A re-evaluation of the mechanism of cellular uptake. J Biol Chem 2003; 278: 585-90.
38. Mier W, Eritja R, Mohammed A, Haberkorn U, Eisenehut M. Peptide-PNA conjugates: targeted transport of antisense therapeutics into tumors. Angewandte Chem Int Ed 2003; 42: 1968-71.
39. Scarfi S, Giovine M, Gasparini A, Damonte G, Millo E, Pozzolini M, et al. Modified peptide nucleic acids are internalized in mouse macrophages RAW 264.7 and inhibit inducible nitric oxide synthase. FEBS Left 1999; 451: 264-8.
40. Aldrian-Herrada G, Desarménien MG, Orcel H, Boissin-Agasse L, Méry J, Brugidou J et al. A peptide nucleic acid (PNA) is more rapidly internalized in cultured neurons when coupled to a retro-inverso delivery peptide. The antisense activity depresses the target mRNA and protein in magnocllular oxytocin neurons. Nucl Acids Res 1998; 26: 4910-6.
41. Basu S, Wickstrom E. Synthesis and characterization of a peptide nucleic acid conjugated to a D-peptide analog of insulin-like growth factor 1 for increased cellular uptake. Bioconj Chem 1997; 8: 481-8.
42. Simmons CG, Pitts AE, Mayfield LD, Shay JW, Corey DR. Synthesis and membrane permeability of FINA-peptide conjugates. Bioorg. Med Chem Lett 1997; 7: 3001-6.
43. Diaz-Mochon JJ, Bialy L, Bradley M. Full orthogonality between Dde and Fmoc: the direct synthesis of PNA-peptide conjugates. Organic Lett 2004; 6: 1127-9.
44. Peyrottes S, Mestre B, Burlina F, Gait MJ. The synthesis of peptide-oligonucleotide conjugates by a fragment coupling approach. Tetrahedron 1998; 54: 12513-22.
45. Zubin EM, Romanova EA, Volkov EM, Tashlitsky VN, Korshonova GA, Shabarova ZA, et al. Oligonucleotide-peptide conjugates as potential antisense agents. FEBS Lett 1999; 456: 59-62.
46. Hwang JT, Greenberg MM. Synthesis of 2′-modified oligodeoxynucleotides via on-column conjugation. J Org Chem 2001; 66: 363-9.
47. Olejnik J, Ludemann HC, Krzymanska-Oiejnik E, Berkenkamp S, Hillenkamp F, Rothschild KJ. Photocleavable peptide-DNA conjugates: synthesis and applications to DNA analysis using MALDI-MS. Nucl Acids Res 1999; 27: 4626-31.
48. Lewis MR, Jia F, Galazzi F, Wang Y, Zhang J, Shenoy N, et al. Radiometal-labeled peptide-PNA conjugates for targeting bcll-2 expression: preparation, characterization, and in vitro mRNA binding. Bioconjugate Chem 2002; 13: 1176-80.
49. Tam JP, Xu J, Eom KD. Methods and strategies of peptide ligation. Biopolymers 2001; 60: 194-205.
50. Arar K, Monsigny M, Mayer R. Synthesis of oligonucleotide-peptide conjugates containing a KDEL signal sequence. Tetrahedron Lett 1993; 34: 8087-90.
51. Eritja R, Pons A, Escarceller M, Giralt E, Albericio F. Synthesis of defined peptide-oligonucleotide hybrids containing a nuclear transport signal sequence. Tehrahedron 1991; 47: 4113-20.
52. Pichon C, Arar K, Stewart AJ, Dodon MD, Gazzolo L, Courtoy PJ, et al. Intracellular routing and inhibitory activity of oligonucleopeptides containing a KDEL motif. Mol Pharmacol 1997; 51: 431-8.
53. Neves C, Byk G, Scherman D, Wils P. Coupling of a targeting peptide to plasmid DNA by covelant triple helix formation. FEBS Lett 1999; 453: 41-5.
54. Good L, Awasthi SK, Dryselius R, Larsson O, Nielsen PE. Bactericidal antisense effects of peptide-PNA conjugates. Nat Biotech 2001; 19: 360-4.
55. Bremner KH, Seymour LW, Logan A, Read ML. Factors influencing the ability of nuclear localization sequence peptides to enhance nonviral gene delivery. Bioconjugate Chem 2004; 15: 152-61.
56. Wei Z, Tung C-H, Zhu T, Dickerhof WA, Breslauer KJ, Georgopoulos DE, et al. Hybridization properties of oligodeoxyrrucleotide pairs bridged by polyarginine peptides. Nucl Acids. Res 1996; 24: 655-61.
57. Soukchareun S, Haralambidis J, Tregear G. Use of Nα-Fmoc-cysteine (S-thiobutyl) derivatized oligodeoxynucleotides for the preparation of oligodeoxynucleotide-peptide hybrid molecules, Bioconj Chemistry 1998; 9: 466-75.
58. Harrison JG, Balasubramanian S. Synthesis and hybridization of a small library of peptide-oligonuelcotide conjugates. Nucl Acids Res 1998; 26: 3136-45.
59. Zanta MA, Belguise-Valladier P, Behr J-P. Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc Natl Acad Sci USA 1999; 96: 91-6.
60. Chiu Y-L, Ali A, Chu C, Cao H, Rana TM. Visualizing a correlation between siRNA, localization, cellular uptake and RNAi in living cells. Chem Biol 2004; 11: 1165-75.
61. Meunier L, Mayer R, Monsigny M, Roche AC. The nuclear export signal-dependent localization of oligonucleopeptides enhances the inhibition of the protein expression from a gene transcribed in the cytosol. Nucl Acids Res 1999; 27: 2730-6.
62. Braun K, Peschke P, Pipkorn R, Lampel S, Wachsmuth M, Waldeck W, et al. A biological transporter for the delivery of peptide nucleic acids (PNAs) to the nuclear compartment of living cells. J Mol Biol 2002; 318: 237-43.
63. Antopolsky M, Azhayeva E, Tengvall U, Autiola S, Jääskeläinen I, Rönkkö S, et al. Peptide-oligonucleotide phosphorothioate conjugates with membrane translocation and nuclear localization properties. Bioconj Chem 1999; 10: 598-606.
64. Corey CR 48000-fold acceleration of hybridisation by chemically modified oligonucleotides. J Amer Chem Soc 1995; 117: 9373-4.
65. Vivès E, Lebleu B. Selective coupling of a highly basic peptide to an oligonucleotide. Tetrahedron Lett 1997; 38: 1183-6.
66. Turner JJ, Arzumanov AA, Gait MJ. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides. Nucl Acids Res 2005; 33: 27-42.
67. Bongartz JP, Aubertin AM, Milhaud PG, Lebleu B. Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide. Nucl Acids Res 1994; 22: 4681-8.
68. Astriab-Fisher A, Sergueev DS, Fisher M, Ramsay Shaw B, Juliano RL. Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates. Biochem Pharmacol 2000; 60: 83-90.
69. Astriab-Fisher A, Sergueev D, Fisher M, Ramsay Shaw B, Juliano RL. Conjugates of antisense oligonucleotides with the Tat and Antennapedia cell-penetrating peptides: effect on cellular uptake, binding to target sequences, and biologic actions. Pharm Res 2002; 19: 744-54.
70. Allinquant B, Hantraye P, Mailleux P, Moya K, Bouillot C, Prochiantz A. Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro. J Cell Biol 1995; 128: 919-27.
71. Troy CM, Derossi D, Prochiantz A, Greene LA, Shelanski ML. Downregulation of Cu/Zn superoxide dismutase lead to cell death via the nitric oxide-peroxynitrite pathway. J Neurosci 1996; 16: 253-61.
72. Chaloin L, Vidal P, Lory P, Mëry J, Lautredou N, Divita G, et al. Design of carrier peptide-oligonucleotide conjugates with rapid membrane translocation and nuclear localization properties. Biochem Biophys Res Comm 1998; 243: 601-8.
73. Kaushik N, Basu A, Palumbo P, Nyers RL, Pandey VN. Anti-TAR polyamide nucleotide analog conjugated with a membrane-permeating peptide inhibits Human Immunodeficiency Virus Type I production. J Virol 2002; 76: 3881-91.
74. Fisher L, Soomets U, Cortes Toro V, Chilton L, Jiang Y, Langel U, et al. Cellular delivery of a double-stranded oligonucleotide NF-kappaB decoy by hybridization to complementary PNA linked to a cell-penetrating peptide. Gene Ther 2004; 11: 1264-71.
75. α-(bromoacetyl)peptides. Bioconj Chem 1995; 6: 573-7.
76. Tian X, Wickstrom E. Continuous solid-phase synthesis and disulfide cyclization of peptide-PNA-peptide chimeras. Organic Lett 2002; 4: 4013-6.
77. Dawson PE, Muir TW, Clark-Lewis I, Kent SBH. Synthesis of proteins by native chemical ligation. Science 1994; 266: 776-9.
78. McPherson M, Wright MC, Lohse PA. Synthesis of an RNA-peptide conjugate by orthogonal ligation. Syn Lett 1999; S1: 978-80.
79. Stetsenko DA, Gait MJ. Efficient conjugation of peptides to oligonucleotides by "native ligation". J Org Chem 2000; 65: 4900-8.
80. De Koning MC, Fillipov DV, Meuuwenoord N, Overhand K van der Marel GA, van Boom JH. Synthesis of PNA-poptide conjugate by chemical ligation. Syn Lett 2001: 1516-8.
81. Petersen L, De Koning MC, van Kuik-Romeijn P, Weterings J, Pol CJ, Platenburg G, et al. Synthesis and in vitro evaluation of PNA-peptide-DETA conjugates as potential cell penetrating artificial ribonucleases. Bioconjugate Chem 2004; 15: 576-82.
82. Forget D, Bouturyn D, Defrancq E, Lhomme J, Dumy P. Highly efficient synthesis of peptide-oligonucleotide conjugates: chemoselective oxime and thiazolidine formation. Chem Eur J 2001; 7: 3976-84.
83. Zatsepin TS, Stetsenko DA, Arzumanov A, Romanova EA, Gait MJ, Oretskaya TS. Synthesis of peptide-oligonucleotide conjugates with single and multiple peptides attached to 2′-aldehydes through thiazolidine, oxime and hydrazine linkages. Bioconjugate Chem 2002; 13: 822-30.
84. Hamma T, Miller PS. 4-(2-aminooxyethoxy)-2-(ethylureido) quinoline-oligonuelcotide conjugates: synthesis, binding interactions, and derivatization with peptides. Bioconjugate Chem 2003; 14: 320-30.
85. Prater CE, Miller P. 3′-Methylphosphonate-modified oligo-2′-O-methytiribonucleotides and their Tat peptide conjugates: uptake and stability in mouse fibroblasts in culture. Bioconjugate Chem 2004; 15: 498-507.
86. Chen C-P, Zhang L-R, Peng Y-F, Wang X-B, Wang S-Q, Zhang L-H. A concise method fbr the preparation of peptide and argininerich peptide-conjugated antisense oligonucleotides. Bieconjugate Chem 2003; 14: 532-8.
87. Jensen ON, Kulkami S, Aldrich JV, Barofsky DF. Characterization of peptide-oligonucleotide heteroconjugates by mass spectrometry. Nucl Acids Res 1996; 24: 3866-72.
88. Tengvall U, Auriola S, Antopolsky M, Azhayev A, Beigelman L. Characterization of antisense oligonucleotide-peptide conjugates with negative ionization electrospray mass spectrometry and liquid chromatography-mass-spectrometry. J Pharm Biomed Anal 2003; 32: 581-90.
89. Mayfield LD, Corey DR. Automated synthesis of peptide nucleic acids and peptide nucleic-acid-peptide conjugates. Anal Biochem 1999; 268: 410-04,
90. Lemaitre M, Bayard B, Lebleu B. Specific antiviral activity of poly (L-lysine)-conjugated oligodeoxyribonucleotide sequence complementary to vesicular stomatitis virus N protein mRNA initiation site. Proc Natl Acad Sci USA 1987; 84: 648-52.
91. Leonetti J-P, Degols G, Lebleu B. Biological activity of oligonucleotide-poly(L-lysine) conjugates: mechanism of cell uptake. Bioconj Chem 1990; 1: 149-53.
92. Degols G, Leonetti J-P, Bekirane M, Devaux C, Lebleu B. Poly(L-lysine)-conjugated oligonucleotides promote sequence-specific inhibition of acute HIV-1 infection. Antisense Res Dev 1992; 2: 293-301.
93. Chen CP, Li XX, Zhang LF, Min JM, Chan JY-H, Fung KP, et al. Synthesis of antisense oligonucleotide-peptide conjugate targeting to GLUT-1 in HepG-2 and MCF-7 cells. Bioconjugate Chem 2002; 13:525-9.
94. Reed MW, Fraga D, Schwartz DE, Scholler J, Hinrichson RD. Synthesis and evaluation of nuclear targeting peptide-antisense oligodeoxynucleotide conjugates. Biocorj Chem 1995; 6: 101-8.
95. Kubo T, Kanno K, Ohba H, Rumiana B, Fujii M. Control of intracellular delivery of oligonucleotides by signal peptides and genetic expression in human cells. Nucl Acids Symposium Series No 48 2004; 303-4.
96. Oehlke J, Birth P, Klauschenz E, Wiesner B, Beyermann M, Oksche A, et al. Cellular uptake of antisense oligonucleotides after complexing or conjugation with cell-penetrating model peptides. Eur J Biochem 2002; 269: 4025-32.
97. Nitin N, Santangelo PJ, Kim G, Nie S, Bao G. Peptide-linked molecular beacons for efficient delivery and rapid mRNA detection in living cells. Nucl Acids Res 2004; 32: e58.
98. Pooga M, Soomets U, Häbrink M, Valkna A, Saar K, Rezaei K, et al. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat Biotech 1998; 16: 857-61.
99. Kaushik MJ, Basu A, Pandey PK. Inhibition of HIV-1 replication by anti-transactivation responsive polyamide nucleotide analog. Antiviral Res 2002; 56: 13-27.
100. Brandén LJ, Mohamed AJ, Smith Cl. A peptide nucleic acids-nuclear localization signal fusion that mediates nuclear transport of DNA. Nat Biotech 1999; 17: 784-7.
101. Brandén LJ, Christensson B, Smith Cl. In vivo nuclear delivery of oligonucleotides via hybridizing bifunctional peptides. Gene Ther 2001; 8: 84-7.
102. Villa R, Folini M, Lualdi S, Veronese S, Daidone MG, Zaffaroni N. Inhibition of telomerase activity by a cell-penetrating peptide nucleic acid construct in human melanoma cells. FEBS Lett 2000; 473: 241-8.
103. Robaczewska M, Narayan I, Siegneres B, Schorr O, Thermetr A, Podhajska AJ, et al. Sequence-specific inhibition of duck hepatitis B virus reverse transcription by peptide nucleic acids (PNA). J Hepatology 2005; 42: 180-7.
104. Koppelhus U, Awasthi SK, Zachar V, Hoist HU, Ebbeson P, Nielsen PE. Cell-dependent differential cellular uptake of PNA, peptides and PNA-peptide conjugates. Antisense Nucl Acid Drug Dev 2002; 12: 51-63.
105. Siwkowski AM, Malik L, Esau CC, Maier MA, Wancewicz EV, Albertshofer K, et al. Identification and functional validation of PNAs that inhibit murine CD40 expression by redirection of splicing. Nucl Acids Res 2004; 32: 2695-706.
106. Oehlke J, Wallukat G, Wolf Y, Ehrlich A, Wiesner B, Berger H, et al. Enhancement of intracellular concentration and biological activity of PNA after conjugation with a cell-penetrating model peptide. Eur J Biochem 2004; 271: 3043-9.
107. Kaihatsu K, Huffman KE, Corey DR. Intracellular uptake and inhibition of gene expression by PNAs and PNA-peptide ponjugates. Biochemistry 2004; 43: 14340-7.
108. Moulton HM, Hase MC, Smith KM, Iversen PL. HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers. Antisense Nucl Acid Drug Dev 2003; 13: 31-43.
109. Moulton HM, Nelson MH, Hatlevig SA, Reddy MT, Iversen PL. Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides. Bioconjugate Chem 2004; 15: 290-9.
110. Nekhotiaeva N, Awasthi SK, Nielsen PE, Good L. Inhibition of Staphylococcus aureus gene expression and growth using antisense peptide nucleic acids. Mol Ther 2004; 10: 652-9.
111. Geller BL, Deere JD, Stein DA, Kroeker AD, Moulton HM, Iversen PL. Inhibition of gene expression in Escherischia coli by antisense phosphorodiamidate morpholino oligoiners. Antimicrob Agents Chemother 2003; 47: 3233-9.
112. Kaihatsu K, Braasch DA, Cansizolglu A, Corey DR. Enhanced strand invasion by peptide nucleic acid-peptide conjugates. Biochemistry 2002; 41: 11118-25.
113. Liu B, Han Y, Ferdous A, Corey DR, Kodadek T. Transcription activation by a PNA-peptide chimera in a mammalian cell extract. Chem Biol 2003; 10: 909-16.
114. Muratovska A, Eccles MR. Conjugate for efficient delivery of short interfering RNA (siRNA) into mamalian cells. FEBS Lett 2004; 558: 63-8.
115. Folini M, Berg K, Millo E, Villa R, Prasmickaite L, Daidone MG, et al. Photochemical internalization of a peptide nucleic acid targeting the catalytic subunit of human telomerase. Cancer Res 2003; 63: 3490-4.
116. Li X, Zhang L, Lu J, Chen Y, Min J, Zhang L. Signal peptide mimics conjugated to peptide nucleic acid: a promising solution for improving cell membrane permeability. Bioconjugate Chem 2003; 14: 153-7.
117. Soomets U, Kilk T, Langel U. Transportan, its analogues and their applications. In: Epton R Ed. Innovations and Perspectives in Solid Phase Synthesis & Combinatorial Libraries 2000. Kingswinford, UK: Mayflower Press 2001; 131-6.
118. Good L, Nielsen PE. Inhibition of translation and bacterial cell growth by peptide nucleic acid targeted to ribosomal RNA. Proc Natl Acad Sci USA 1998; 95: 2073-6.
119. Tian X, Aruva MR, Rao PS, Qin W, Read P, Sauter ER, et al. Imaging oncogene expression. Ann NY Acad Sci 2003; 1002: 165-88.
120. Garcia EA, Newhouse S, Caulfield MJ, Munroe PB. Genes and hypertension. Curr Pharm Design 2003; 9(21): 1679-89.
121. Schiavone N, Donnini M, Nicolin A, Capaccioli S. Antisense oligonucleotide drug design. Curr Pharm Design 2004; 10(7): 769-84.
122. Shoji Y, Nakashima H. Current status of delivery systems to improve target efficacy of oligonucleotides. Curr Pharm Design 2004; 10(7): 785-96.